Table 5 Clinical data of survivors with HHS before discharge

Number of patients

29

29

Age (year)

74.8 ± 12.5

74.5 ± 12.3

Gender (male: female)

11:18

8:21

Hospital stay (days)

19.83 ± 14.68

19.52 ± 11.11

Expenses (Yuan)

15,836.9 ± 6302.6

18,139.4 ± 14,163.8

FBG (mmol/L)

10.68 ± 3.47

8.54 ± 2.77*

EPO (mOsm/L)

298.70 ± 10.87

300.87 ± 8.59

Na⁺(mmol/L)

137.76 ± 3.50

139.62 ± 3.37

BUN (mmol/L)

5.99 ± 4.49

5.82 ± 3.12

Cr (umol/L)

75.75 ± 34.10

73.15 ± 30.57

Total number of times that blood glucose monitoring was performed during MDI or CSII therapy

1523

1756

Total number of hypoglycemic events during MDI or CSII therapy

15

16

Percentage of Severe hypoglycemic events (%)

26.7 (4/15)

0 (0/16)*

Number of subjects experiencing hypoglycemia

7

5